Advertisement

Targeted Medical Pharma, Inc. Company Profile

09:09 EDT 22nd May 2013 | BioPortfolio

Physician Therapeutics is a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and sells prescription medical foods to physicians, pharmacies and skilled nursing facilities for the treatment of pain syndromes, obesity, sleep and cognitive disorders. Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are sold in the United States and Japan. The company manufactures nine proprietary medical food products, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical. These prescription medical food products and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs.


News Articles [ 1613 Associated News Articles listed on BioPortfolio]

Targeted Medical opts for loans and other funding over IPO

Los Angeles-based Targeted Medical Pharma has withdrawn its registration for an initial public offering in which it planned to raise up to $117.7 million in favour of loans, private stock sales and fa...

Targeted Medical Pharma to Present at 5TH Annual LD Micro Growth Conference

Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharma...

Targeted Medical Pharma to Present at OneMedForum Healthcare Conference

Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pha...

Pfizer pharma partners with BIND Therapeutics for Accurins

BIND Therapeutics pharma partners with Pfizer, a big pharma company, to develop and commercialize Accurins utilizing select small molecule targeted therapies. The collaboration aims to employ BIND’s...

BIND pharma partners with Big Pharma company AstraZeneca for Accurins development

Pharma partners BIND and AstraZeneca, a Big Pharma company, work to develop Accurins, a targeted and programmable cancer nanomedicine, in $199 million partnering terms. BIND Therapeutics and big pha...

Targeted Medical Commences Public Trading of Its Securities

Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharmacies and skilled nursing fac...

USPTO grants notice of issuance to Targeted Medical comprehensive billing patent

Los Angeles-based Targeted Medical Pharma has obtained a notice of issuance for its projected patent number 8370172 from the US Patent and Trademark Office (USPTO).

Targeted Medical Pharma to Present at Upcoming Investor Conferences

Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharma...

Drugs and Medications [ 255 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [ 333 Associated PubMed Articles listed on BioPortfolio]

New Insights on the Mechanism of PPAR-targeted Drugs.

Comment about the article "Psychopharmaceuticals and diabetes" of Ress C, Tschoner A, Kaser S, and Ebenbichler CF in Wiener Medizinische Wochenschrift 2011; 161/21-22: 531-42.

FDA and pharma seek better ways to assess drug safety, efficacy in clinical trials.

Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.

Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...

Anticancer drug development from traditional cytotoxic to targeted therapies: evidence of shorter drug research and development time, and shorter drug lag in Japan.

What is known and Objective:  Concern about the drug lag, the delay in marketing approval between one country and another, for anticancer drugs has increased in Japan. Although a number of studies h...

Clinical Trials [ 1099 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Tailored Messages to Increase Eye Examination Behavior

The purpose of this project is to test two different types of health messages, one that is developed for a specific group (targeted) and the other that is more personalized to individuals...

Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia

This study will determine the effectiveness of reward-intensive, computer-based targeted cognitive training in improving neurocognitive deficits in people with schizophrenia.

Companies [ 2000 Associated Companies listed on BioPortfolio]

U3 Pharma AG

U3 Pharma AG is an emerging leader in targeted cancer drug development. The company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder...

Targeted Medical Pharma, Inc.

Physician Therapeutics is a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and sells prescription medical foods to physi...

BioAlliance Pharma SA

Dedicated to cancer and supportive care – cancer related pathologies, chemotherapy and radiotherapy-induced complications and opportunistic infections in immunocompromised pa...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...

Circ Pharma Limited

Circ Pharma is a specialty pharmaceutical product development company whose mission is to develop differentiated novel formulations of products based on existing drugs that provide incremental pat...

More Information about "Targeted Medical Pharma, Inc." on BioPortfolio

We have published hundreds of Targeted Medical Pharma, Inc. news stories on BioPortfolio along with dozens of Targeted Medical Pharma, Inc. Clinical Trials and PubMed Articles about Targeted Medical Pharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Targeted Medical Pharma, Inc. Companies in our database. You can also find out about relevant Targeted Medical Pharma, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement